Brief: Dimerix Says First Approvals Received For Start Of Phase 3 FSGS Trial
21/10/2021 01:20
Oct 21 (Reuters) - Dimerix Ltd DXB.AX :
* FIRST APPROVALS RECEIVED FOR START OF PHASE 3 FSGS TRIAL
* EXPECTS RECRUITMENT TO BEGIN THIS QUARTER
Source text for Eikon: ID:nASX161f2p
Further company coverage: DXB.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Dimerix
See all newsAustralia's Dimerix soars on commercialisation deal with Everest Medicines
Brief: Dimerix Ltd Licenses Dmx200 To Everest For China And Asia Region
Brief: Everest Medicine In Agreement With Dimerix To Develop Commercialize DMX-200 In Greater China, South Korea, And Southeast Asia
Brief: Dimerix Seeks Trading Halt
Brief: Dimerix To Conduct Review Of Action3 Statistical Assumptions